Drug Shortage Report for CIPROFLOXACIN
Report ID | 211200 |
Drug Identification Number | 02353326 |
Brand name | CIPROFLOXACIN |
Common or Proper name | CIPROFLOXACIN |
Company Name | SANIS HEALTH INC |
Market Status | DORMANT |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-27 |
Estimated end date | 2024-05-01 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-03-31 | French | Compare |
v3 | 2024-03-31 | English | Compare |
v2 | 2023-11-22 | French | Compare |
v1 | 2023-11-22 | English | Compare |
Showing 1 to 4 of 4